Prostaglandin analogues (PGAs) are synthetic, first-line, once-daily eye drops that reduce elevated intraocular pressure (IOP) in glaucoma and ocular hypertension by increasing uveoscleral outflow. These compounds mimic naturally occurring prostaglandins, specifically targeting receptors to relax eye muscles and enhance aqueous humor drainage.   There is no formal ban on the use of prostaglandin analogues in cosmetic products in the EU as of March 2026. However, the situation is very close to...

Reproductive Toxicity Category 1B and hazard statement May damage fertility. May damage the unborn child. In November 2023, the Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA) adopted an opinion to classify Tea Tree Oil (Melaleuca alternifolia) as a Category 1B Reproductive Toxicant (Repr. 1B - H360) under the EU Classification, Labelling, and Packaging (CLP) regulation. This classification indicates a high, harmonized concern that the substance may damage fertility or...

Life Cycle Sustainability Assessment (LCSA ) Alignment with ISO Standards, PPWR, and CSRD Requirements.   Life Cycle Sustainability Assessment (LCSA ) is increasingly recognized as a key analytical framework supporting regulatory compliance, sustainability reporting, and product stewardship in the cosmetics sector. While LCSA is not explicitly mandated for cosmetic products, its components are directly relevant to ISO life cycle standards, the EU Packaging and Packaging Waste Regulation...